Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs (CROSBI ID 180140)

Prilog u časopisu | kratko priopćenje

Mihovilović, Karlo ; Ljubanović, Danica ; Knotek, Mladen Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs // Clinical drug investigation, 31 (2011), 5; 351-355. doi: 10.1007/BF03256934

Podaci o odgovornosti

Mihovilović, Karlo ; Ljubanović, Danica ; Knotek, Mladen

engleski

Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs

Nephrotic syndrome, with or without concomitant tubulointerstitial nephritis, is a rare renal adverse effect of NSAIDs. In the present report we describe a case of a 60-year-old Caucasian man who was admitted because of nephrotic syndrome following several days of use of meloxicam for hip osteoarthritis. Renal histopathology revealed minimal change disease, one of the commonest causes of nephrotic syndrome. The patient's condition resolved rapidly upon discontinuation of meloxicam. Because he had already experienced two episodes of nephrotic syndrome after administration of diclofenac several years previously, it was concluded that the patient had renal hypersensitivity to both diclofenac and meloxicam. While waiting for the hip arthroplasty, he was prescribed celecoxib for pain control. After 1 month of regular celecoxib use the patient remained in remission with respect to nephrotic syndrome and had normal renal function. We conclude that challenge with a structurally distinct NSAID (such as celecoxib in this case) may be an option, under close surveillance, in a patient with a history of nephrotic syndrome associated with use of an NSAID when continued treatment with an NSAID is indicated.

NSAD ; nephrotic syndrome ; MCD

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

31 (5)

2011.

351-355

objavljeno

1173-2563

10.1007/BF03256934

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost